Plasma Levels of Plasminogen Activator Inhibitor Type 1 and Vitronectin in Children With Cancer

Conclusions: This is a preliminary study done in children with malignancies, investigating PAI-1 and vitronectin. Further study is needed, including larger trials and tumor tissue with histopathological examination as in adults.

http://cat.sagepub.com/cgi/content/abstract/22/1/28?rss=1

Source: Clinical and Applied Thrombosis/Hemostasis - December 9, 2015 Category: Hematology Authors: Tugcu, D., Devecioglu, O., Unuvar, A., Ekmekci, H., Ekmekci, O. B., Anak, S., Ozturk, G., Akcay, A., Aydogan, G. Tags: Original Articles Source Type: research